Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.63 |
| ▸ | DHFR | P00374 | 1/20 | 0.56 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.48 |
| ▸ | GCGR | P47871 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CRHBP | P24387 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | SOAT1 | P35610 | 3/20 | 0.44 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15068307 | 1.00 | GPR84 (0.63) | GPR84DHFRHSD11B1KCNH2GCGR | |
| SCHEMBL626394 | 0.79 | KCNH2 (0.53) | DHFRKCNH2TDP1L3MBTL1TLR8 | |
| SCHEMBL27905824 | 0.79 | KCNH2 (0.53) | DHFRKCNH2TDP1L3MBTL1TLR8 | |
| SCHEMBL27863633 | 0.79 | KCNH2 (0.53) | DHFRKCNH2TDP1L3MBTL1TLR8 | |
| SCHEMBL13505969 | 0.76 | GCGR (0.44) | GPR84DHFRHSD11B1KCNH2GCGR | |
| SCHEMBL8518275 | 0.76 | TLR8 (0.50) | DHFRKCNH2TDP1L3MBTL1TLR8 | |
| SCHEMBL12628223 | 0.75 | HSD11B1 (0.62) | GPR84HSD11B1KCNH2MEN1KMT2A | |
| Biphenyl SCHEMBL5868587 | 0.75 | ALDH1A1 (0.53) | GPR84MEN1CYP1A2CYP2C9CYP2C19 | |
| Hexadecane SCHEMBL8524813 | 0.75 | ALDH1A1 (0.53) | GPR84MEN1CYP1A2CYP2C9CYP2C19 | |
| Biphenyl SCHEMBL27853080 | 0.75 | ALDH1A1 (0.53) | GPR84MEN1CYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130172457-A1 | Phosphorus-Containing Mixtures, Processes for Preparing Them and Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2013-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130172457-A1 | Phosphorus-Containing Mixtures, Processes for Preparing Them and Use Thereof | C9, PHOSPHO1, C5 | GPR84 3173/4885DHFR 3169/4885HSD11B1 1004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.